Clinical trial
Comparative Evaluation of Magnesium Sulphate Versus Neostigmine as an Adjuvant to Bupivacaine in Ultrasound Guided Transversus Abdominis Plane (TAP) Block as Postoperative Analgesia in Cesarean Section
NCT06513013 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparative Evaluation of Magnesium Sulphate Versus Neostigmine as an Adjuvant to Bupivacaine in Ultrasound Guided Transversus Abdominis Plane (TAP) Block as Postoperative Analgesia in Cesarean Section
- Lead sponsor
- Assiut University
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- December 20, 2023
- Completion date
- January 18, 2026
- Enrollment
- 68 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cesarean section